Latest filing published 10 Feb 2026 for Dynavax Technologies CORP.
Insider track record
Elaine D. Sun: trading record in brief
Elaine D. Sun discloses dealings in 3 companies, chiefly Dynavax Technologies Corp, Halozyme Therapeutics, Inc. and Recursion Pharmaceuticals, Inc. We count 10 filings; the first trade dates from 2 March 2021 and the latest from 10 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 10 February 2026 with a transaction in Dynavax Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elaine D. Sun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 29,865 sharesCommon Stock - Restricted Stock UnitsSEC:0001805339-26-000002:0
- 11,008 shares0Class A Common StockSEC:0001601830-25-000106:0
- 5,758 shares0Common StockSEC:0001029142-25-000095:0
- 36,549 shares0Class A Common StockSEC:0001601830-25-000047:0
- 5,357 shares0Common StockSEC:0000950170-24-065573:0
- 5,357 shares0Common StockSEC:0001209191-23-033176:0
- 4,059 shares@ US$42.4347.7% of flowCommon StockSEC:0001179110-21-003974:1
- 10,196 shares0Common StockSEC:0001179110-21-003974:0
- 4,285 shares@ US$45.0152.3% of flowCommon StockSEC:0001179110-21-002560:1
- 12,166 shares0Common StockSEC:0001179110-21-002560:0
10 of 10 declarations
